GLAXO.NS · GlaxoSmithKline Pharmaceuticals Limited
India · RS rating 56 · As of 2026-10-14
| Price | 2,538.90 INR |
|---|---|
| 1-day change | +0.1% |
| RS rating (overall / 1M / 3M / 12M) | 56 / 17 / 67 / 57 |
| Stage | Topping |
| Composite / Minervini / CANSLIM score | 30 / 25 / 38 |
| Industry group (rank) | Pharma (32) |
| EPS growth Q/Q | -14.6% |
| Sales growth Q/Q | -5.7% |
| Distance from 52-week high | +18.3% |
| Market cap (USD) | $4.5B |